Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amazon.com, Inc. stock logo
AMZN
Amazon.com
$225.34
-1.6%
$224.91
$161.38
$242.52
$2.44T1.333.88 million shs38.73 million shs
DexCom, Inc. stock logo
DXCM
DexCom
$74.30
-1.4%
$81.90
$57.52
$93.25
$29.54B1.483.74 million shs4.47 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amazon.com, Inc. stock logo
AMZN
Amazon.com
-1.60%-1.47%+4.93%+8.74%+26.24%
DexCom, Inc. stock logo
DXCM
DexCom
-1.38%-2.39%-6.28%-13.21%+7.15%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amazon.com, Inc. stock logo
AMZN
Amazon.com
4.7389 of 5 stars
3.53.00.03.02.83.32.5
DexCom, Inc. stock logo
DXCM
DexCom
4.9767 of 5 stars
4.53.00.04.73.02.53.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amazon.com, Inc. stock logo
AMZN
Amazon.com
3.00
Buy$262.8716.66% Upside
DexCom, Inc. stock logo
DXCM
DexCom
2.95
Moderate Buy$99.8934.45% Upside

Current Analyst Ratings Breakdown

Latest DXCM and AMZN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/21/2025
DexCom, Inc. stock logo
DXCM
DexCom
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$100.00
8/19/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Zacks Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/14/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$300.00
8/13/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
8/13/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$280.00
8/13/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$265.00
8/1/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
8/1/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
8/1/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$270.00 ➝ $280.00
8/1/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$230.00 ➝ $265.00
8/1/2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$250.00 ➝ $245.00
(Data available from 9/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amazon.com, Inc. stock logo
AMZN
Amazon.com
$637.96B3.77$10.40 per share21.66$31.30 per share7.20
DexCom, Inc. stock logo
DXCM
DexCom
$4.03B7.22$2.22 per share33.52$6.56 per share11.33
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amazon.com, Inc. stock logo
AMZN
Amazon.com
$59.25B$6.5634.3530.291.5410.54%23.84%11.14%10/30/2025 (Estimated)
DexCom, Inc. stock logo
DXCM
DexCom
$576.20M$1.4451.6030.201.5813.29%30.41%10.08%10/23/2025 (Estimated)

Latest DXCM and AMZN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/31/2025Q2 2025
Amazon.com, Inc. stock logo
AMZN
Amazon.com
$1.31$1.68+$0.37$1.68$161.80 billion$167.70 billion
7/30/2025Q2 2025
DexCom, Inc. stock logo
DXCM
DexCom
$0.45$0.48+$0.03$0.45$1.13 billion$1.16 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amazon.com, Inc. stock logo
AMZN
Amazon.com
N/AN/AN/AN/AN/A
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amazon.com, Inc. stock logo
AMZN
Amazon.com
0.15
1.02
0.81
DexCom, Inc. stock logo
DXCM
DexCom
0.48
1.52
1.35

Institutional Ownership

CompanyInstitutional Ownership
Amazon.com, Inc. stock logo
AMZN
Amazon.com
72.20%
DexCom, Inc. stock logo
DXCM
DexCom
97.75%

Insider Ownership

CompanyInsider Ownership
Amazon.com, Inc. stock logo
AMZN
Amazon.com
10.80%
DexCom, Inc. stock logo
DXCM
DexCom
0.32%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amazon.com, Inc. stock logo
AMZN
Amazon.com
1,556,00010.66 billion9.51 billionOptionable
DexCom, Inc. stock logo
DXCM
DexCom
10,300392.15 million390.90 millionOptionable

Recent News About These Companies

Ieq Capital LLC Acquires 11,437 Shares of DexCom, Inc. $DXCM
Argus Initiates Coverage of DexCom (DXCM) with a Buy Rating

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Amazon.com stock logo

Amazon.com NASDAQ:AMZN

$225.34 -3.66 (-1.60%)
Closing price 09/2/2025 04:00 PM Eastern
Extended Trading
$225.92 +0.58 (+0.26%)
As of 05:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Amazon.com, Inc. engages in the retail sale of consumer products, advertising, and subscriptions service through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). It also manufactures and sells electronic devices, including Kindle, Fire tablets, Fire TVs, Echo, Ring, Blink, and eero; and develops and produces media content. In addition, the company offers programs that enable sellers to sell their products in its stores; and programs that allow authors, independent publishers, musicians, filmmakers, Twitch streamers, skill and app developers, and others to publish and sell content. Further, it provides compute, storage, database, analytics, machine learning, and other services, as well as advertising services through programs, such as sponsored ads, display, and video advertising. Additionally, the company offers Amazon Prime, a membership program. The company's products offered through its stores include merchandise and content purchased for resale and products offered by third-party sellers. It serves consumers, sellers, developers, enterprises, content creators, advertisers, and employees. Amazon.com, Inc. was incorporated in 1994 and is headquartered in Seattle, Washington.

DexCom stock logo

DexCom NASDAQ:DXCM

$74.30 -1.04 (-1.38%)
Closing price 09/2/2025 04:00 PM Eastern
Extended Trading
$74.48 +0.19 (+0.25%)
As of 04:55 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.